Inventor · disambiguated record
Vijay H. Naringrekar
Also filed as: NARINGREKAR VIJAY · NARINGREKAR VIJAY H
19 granted patents·19 pending applications·309 citations·filing 1989–2024
95Inventor score
Files withBRISTOL MYERS SQUIBB CO13OTSUKA PHARMA CO LTD10CELGENE CORP7DALI MANISHA M2KOSTANSKI JANUSZ W2
Top patents by PatentIndex Score
38 records- 0197US7550445B2Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 23, 2009·51 cites·8 claims
- 0296US8030313B2Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2007·Granted Oct 4, 2011·37 cites·35 claims
- 0396US7807680B2Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2004·Granted Oct 5, 2010·63 cites·38 claims
- 0496US7115587B2Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 3, 2006·69 cites·24 claims
- 0591US9309316B2Stable subcutaneous protein formulations and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 12, 2016·14 cites·44 claims
- 0690US8722679B2Controlled release sterile injectable aripiprazole formulation and methodKOSTANSKI JANUSZ W·Filed 2007·Granted May 13, 2014·12 cites·36 claims
- 0790US8476239B2Stable protein formulationsDALI MANISHA M·Filed 2006·Granted Jul 2, 2013·40 cites·15 claims
- 0890US2024261280A1Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0986US7534763B2Sustained release GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 19, 2009·5 cites·25 claims
- 1080US9763935B2Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2014·Granted Sep 19, 2017·2 cites·7 claims
- 1180US8952013B2Controlled release sterile injectable aripiprazole formulation and methodKOSTANSKI JANUSZ W·Filed 2011·Granted Feb 10, 2015·3 cites·39 claims
- 1279US2021338663A1Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1377US2023277672A1METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONSBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1473US10265401B2Stable subcutaneous protein formulations and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 23, 2019·1 cites·16 claims
- 1572US2020061057A1Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1668US2009186903A1Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 1768US2015051157A1Romidepsin formulations and uses thereofCELGENE CORP·Filed 2014·Application pending·0 cites
- 1867US9795650B2Romidepsin formulations and uses thereofCELGENE CORP·Filed 2016·Granted Oct 24, 2017·0 cites·12 claims
- 1967US9782451B2Romidepsin formulations and uses thereofCELGENE CORP·Filed 2016·Granted Oct 10, 2017·0 cites·12 claims
- 2067US2018360965A1Stable subcutaneous protein formulations and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 2166US2017348308A1Controlled release sterile injectable aripiprazole formulaton and methodOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 2266US2020230242A1METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONSBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2365US9463215B2Romidepsin formulations and uses thereofCELGENE CORP·Filed 2015·Granted Oct 11, 2016·0 cites·6 claims
- 2465US8999952B2Aripiprazole complex formulation and methodOTSUKA PHARMA CO LTD·Filed 2013·Granted Apr 7, 2015·0 cites·6 claims
- 2565US2014018369A1Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2664US2015182584A1Romidepsin formulations and uses thereofCELGENE CORP·Filed 2014·Application pending·0 cites
- 2762US2013045981A1Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 2860US9468664B2Romidepsin formulations and uses thereofCELGENE CORP·Filed 2015·Granted Oct 18, 2016·0 cites·6 claims
- 2959US8871227B2Process and formulation containing epothilones and analogs thereofHABY THOMAS A·Filed 2009·Granted Oct 28, 2014·0 cites·8 claims
- 3059US2016367625A1Romidepsin formulations and uses thereofCELGENE CORP·Filed 2016·Application pending·0 cites
- 3159US2012053145A1Aripiprazole complex formulation and methodNERURKAR MANOJ·Filed 2011·Application pending·0 cites
- 3258US7053069B2Pharmaceutical compositions and methods of using C-21 modified epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 30, 2006·1 cites·75 claims
- 3358US2011160224A1Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 3457US2015328335A1Aripiprazole complex forumlation and methodOTSUKA PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 3553US2005171167A1Process and formulation containing epothilones and analogs thereofFiled 2004·Application pending·0 cites
- 3651US2010022457A1Sustained release glp-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 3744US5059619AStable freeze-dried polyhematoporphyrin ether/esterQUADRA LOGIC TECH INC·Filed 1989·Granted Oct 22, 1991·11 cites·6 claims
- 3828US2012035177A1Tablet formulation for p38 inhibitor and methodDALI MANISHA M·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vijay H. Naringrekar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →